EUNETWORKS
9.9.2021 10:02:12 CEST | Business Wire | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, today announced that it has completed a strategic investment of critical fibre-based internet infrastructure linking London and Amsterdam, including the delivery of a new subsea high fibre count cable system named Scylla that is now in service. This is the first subsea cable system between the UK and the Netherlands since 1999.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210909005383/en/
euNetworks builds and invests in its city and long haul fibre networks to connect the key data centres and data centre hubs across the UK and Europe. The company builds Super Highways on long haul routes that are critical to Europe’s future international bandwidth needs and uses low loss fibre on these routes to deliver a low cost per bit long haul solution for its customers.
This latest state of the art, ultra high capacity fibre system extends euNetworks’ unique Super Highway network onto the Continent after delivering Super Highway 1 linking Dublin and London to Lowestoft in November 2019. euNetworks’ second Super Highway links Lowestoft via the new submarine cable Scylla to IJmuiden and then onto Amsterdam. Combined with euNetworks’ extensive metro networks in Dublin , Manchester , London and Amsterdam , the system enables any data centre to any data centre connectivity between all these metros on euNetworks’ owned and operated fibre, end-to-end.
Detailed design and permitting studies were initiated in August 2019, construction started in April 2020 and services were delivered to customers at the beginning of September 2021. This low loss network is entirely new fibre deployment. The terrestrial backhaul networks utilise new low-loss Corning SMF28 Ultra G657.A1 fibre cables and three entirely new amplification sites for the two cable landings and intermediate repeater in the UK. With existing sites and backhauls built over 20 years ago, these new facilities eliminate the unreliability of old infrastructure and provide scalable and power-efficient amplification housing, with significantly reduced long-run power demands.
Scylla itself is a non-hybrid 96 pair double-armoured sea cable, solely using Corning’s SMF28 ULL (ultra-low loss) G654.C pure silica fibre; giving all customers the benefit of future-proofed ultra-low attenuation on the 211km (cable landing station to cable landing station) unrepeatered system. This low attenuation is critical to achieving lowest cost per bit, directly driving greater bandwidth per fixed-cost transponder.
The North Sea has traditionally been a hostile environment for subsea cables, with a combination of high water current, a mobile sandy seabed and intense fishing presenting regular service challenges due to cable cuts. euNetworks planned and developed Scylla using new technology to both minimise these risks and also to lower the environmental impact from the cable laying process. During planning and mapping, the seabed was modelled to identify sand wave movement together with fishing intensity in areas with historic cable strikes. This highlighted potential areas of risk for the cable lay and subsequent path modification or planned deeper cable burial. euNetworks also used an innovative cable laying technique for telecom cables, utilising a CAPJET trenching system – a high powered water jet more commonly used for power cables – to create the 2-3 metre deep but narrow trench for the cable to lay in. The CAPJET uniquely enables greater precision and ‘micro-routing’ during the cable lay process. The remotely operated system with on-board telemetry allows for steering in real-time. The low ploughing tension allows for quick manoeuvrability, delivering a finer cable lay plan, burial between the troughs in natural sand formations and subsequent deeper burying of the cable over time. This contrasts with a traditional ploughed burial, which may achieve theoretically similar depths, but must follow much straighter paths over sand waves with amplitudes of 8m and pitches of 12o . Such an approach creates risks to the initial lay, uneven burial depth and still leaves the probability of the cable becoming unburied over time. As well as ensuring deeper burial naturally, laying the cable with precision and less impact on the seabed, euNetworks has buried Scylla up to 3 metres deep versus typical 0.7 metres for existing systems, offering better protection against strikes both today and in the future.
On land the company has also designed and planned this new network with sustainability in mind. The route is designed with optimal spacing and attenuation loss between amplifier sites, meaning less ILA/PoP sites compared to other routes in service. The use of modern fibre types plus a reduction in ILA sites along the route meant less construction during deployment, less resources and less power consumption in service. In addition, the technology used within the new ILA sites is new, with more efficient air conditioning monitoring the air being drawn in and hence using less power when cooling. Overall this approach delivers a much lower power consumption per bit and delivers an optimised low carbon footprint network infrastructure.
“This Super Highway is an important investment in Western European bandwidth infrastructure,” said Brady Rafuse, Chief Executive Officer of euNetworks. “We’ve delivered the first new subsea cable on this important route in 20 years and delivered a unique route running between London and Amsterdam to support the many businesses whose connectivity requirements continue to grow. Critically for our customers, this network development continues our approach of delivering highly scalable, owned and operated fibre based sustainable infrastructure to support their needs.”
“We extend our thanks to all those who have worked with us on this project. We look forward to continuing to work closely with our customers in these regions and across our networks, delivering the bandwidth experience and scale they need,” said Rafuse.
About euNetworks
euNetworks is a bandwidth infrastructure company, owning and operating 17 fibre based metropolitan networks connected with a high capacity intercity backbone covering 51 cities in 15 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 450 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210909005383/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 07:00:00 CEST | Press release
The ruling confirms that Beerenberg did not infringe Aspen Aerogels’ patents. The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. Th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
